Pfizer increases annual profit forecast amid solid demand for blood thinner drug
Open the sourceReported by Investing.com, investing.com, 3 November 2026, by Investing.com
50Impact 50 of 100, routine
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at investing.com.
Named in this story
Pfizer (PFE), blood thinner drug
A linked name opens that asset's sentiment page.